NCT04965090 2025-12-18A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)Memorial Sloan Kettering Cancer CenterPhase 2 Completed43 enrolled
NCT05862194 2023-08-22Retrospective, External Comparator Study of Lazertinib as the 2nd-Line Treatment in Patients With EGFR Mutation+ NSCLCYuhan CorporationCompleted534 enrolled